JNJ · Discounted Cash Flow Valuation

J&J DCF Valuation: Intrinsic Value Calculator

Johnson & Johnson (JNJ) DCF model with live financials. See the pre-loaded intrinsic value estimate below, then adjust growth and discount rate assumptions in the full calculator.

DCF Snapshot

Current Price$238.46

Market Cap$574.7B

TTM Free Cash Flow$16.6B

Intrinsic Value / Share$131.48

Upside / Downside-44.9%

Assumptions

FCF Growth Rate5%

Discount Rate (WACC)9%

Terminal Growth2.5%

Projection Period10 years

These are conservative starting assumptions. Adjust them in the full calculator to test your own thesis.

What Drives J&J's DCF

J&J's DCF reflects its transformation into a focused pharmaceutical and medtech company following the Kenvue consumer health spinoff. The Innovative Medicine segment (~55% of revenue) is powered by blockbusters like Darzalex, Tremfya, and pipeline assets in oncology and immunology. Key assumptions: mid-single-digit growth as new launches offset biosimilar erosion on legacy drugs, MedTech benefits from an aging population and procedure volume recovery, and the AAA-rated balance sheet supports acquisitions to replenish the pipeline.

Adjust these assumptions in the full DCF calculator →Get the full analysis →

More tools & guides

DCF Calculator

Run a full DCF on any ticker with live data

DCF Analysis Guide

The complete guide to building and stress-testing a DCF model

Intrinsic Value Calculator

Compare DCF, earnings power, and asset-based valuations side by side